Live Quote · NASDAQSABSHealthcare· Biotechnology

SAB Biotherapeutics, Inc.

$2.81▼ 3.44%($-0.10)
MKT CAP $253.15MNEXT EARNINGS Mar 8, 2027
50%
Bullish
TickerSpark Score
53/100
▌ Mixed
80
Valuation
20
Profitability
55
Growth
80
Health
30
Momentum

Built from real-time financials, refreshed daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a SABS research report →

Analyst Price Target
$12.00+327.0% vs. today

Range $11 – $13

Analyst RatingBuy
7 Buy1 Hold0 Sell

Price Chart

-26.05% · this period
$4.59$3.54$2.49Nov 20May 26Nov 20
52-Week Range14% of range
Low
$2.44
Current
$2.81
High
$5.15